Navigation Links
NYU Langone researchers identify a signaling pathway as possible target for cancer treatment
Date:8/15/2011

In a new study published in the August 16th issue of Developmental Cell, researchers at NYU Langone Medical Center identified a molecular mechanism that guarantees that new blood vessels form in the right place and with the proper abundance.

"We have known for a long time that blood vessels branch to give rise to new ones and that in some places of our bodies this branching occurs with a reproducible pattern. However, the mechanisms that ensure that new vessels sprout at specific locations had not been uncovered until now," said Jess Torres-Vzquez, PhD, assistant professor of Developmental Genetics at the Skirball Institute of Biomolecular Medicine at NYU School of Medicine. "Our study illuminates the genetic basis behind the reproducible pattern of the vasculature and suggests ways in which the formation of new blood vessels could be modulated to treat certain cancers in the future."

Using the zebrafish embryo as a model system, researchers identified that Semaphorin-PlexinD1 signaling limits the formation of new blood vessels. This signaling pathway works by ensuring that blood vessels make the proper levels of soluble Flt1. Soluble Flt1 is an inhibitor of the Vascular Endothelial Growth Factor (VEGF) pathway, which promotes the growth of new blood vessels.

These findings have broad implications for human health, since changes in the level of soluble Flt1 are associated with cancer, vascular birth defects and pregnancy-related hypertension (preeclampsia).

According to researchers, the Semaphorin-PlexinD1 signaling pathway shows significant promise as a future therapeutic target for cancer treatment to slow the progression of diseases by controlling the blood vessel growth.


'/>"/>

Contact: Christopher Rucas
christopher.rucas@nyumc.org
212-404-3525
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Page: 1

Related biology news :

1. NYU Langone Medical Centers tip sheet to the 2011 Alzheimers Association International Conference
2. NYU Langone experts present advances at American Association of Neurological Surgeons Meeting
3. NYU Langone Medical Center receives $5.4 million NYSTEM grant for stem cell research
4. NYU Langone Medical Center awarded NIH grants totaling $1,560,000
5. NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis
6. Toronto researchers first to discover new genetic clue in the development of rheumatoid arthritis
7. Researchers decode workings of mysterious, but critical TB drug
8. Researchers fight cholera with computer forecasting
9. Vanderbilt researchers, international team, uncover genes linked to multiple sclerosis
10. Narcissism may benefit the young, researchers report; but older adults? Not so much
11. York U researchers zero in on protein that may help treat obesity, diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... India , March 23, 2017 The report "Gesture ... Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, ... at a CAGR of 29.63% between 2017 and 2022. ... ... ...
(Date:3/22/2017)... March 21, 2017 Vigilant Solutions , ... law enforcement agencies, announced today the appointment of retired ... of public safety business development. Mr. Sheridan ... experience, including a focus on the aviation transportation sector, ... recent position, Mr. Sheridan served as the Aviation Liaison ...
(Date:3/13/2017)... , March 13, 2017 Future of security: Biometric ... ... DERMALOGs Face Matching enables to match face pictures ... the basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for biometric Face ...
Breaking Biology News(10 mins):
(Date:4/27/2017)... RESEARCH TRIANGLE PARK, N.C. , April 27, ... UTHR ) today announced that its Board of Directors ... the company,s common stock. This program will became effective ... Purchases may be made in the open market, accelerated ... to time as determined by United Therapeutics, management and ...
(Date:4/27/2017)... SEATTLE, WA (PRWEB) , ... April 27, 2017 ... ... a revolutionary, cloud-based and secure electronic informed consent (eConsent) solution that simplifies research ... the technology and consulting division of Quorum, Q Consent™ is the first ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... name change to Fluence Analytics. , Fluence Analytics provides proprietary hardware ... biopharmaceutical manufacturing processes and R&D applications. The company’s patented technologies improve production ...
(Date:4/27/2017)... a distinguished resource for research, development and commercialization of ... Thomas C. Seoh as President and CEO. Mr. Seoh ... becomes Executive Chairman and will continue to serve as ... Thomas Seoh commented, "I am excited and honored ... firm,s remarkable team of life science professionals, all of ...
Breaking Biology Technology: